{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:22:51Z","timestamp":1767705771896,"version":"3.40.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Jianwei Ruan","award":["2020KY367"],"award-info":[{"award-number":["2020KY367"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Melanoma can spread to the bone by metastasis and is relevant to a poor outcome. However, because of the rarity of melanoma patients with bone metastasis, the prognostic postoperative survival factors of them have not been elucidated. The aim of this special population-based cohort was to elucidate the prognostic factors associated with postoperative survival. The Surveillance, Epidemiology, and End Results database was used to extract postoperative survival data relating to patients with melanoma and bone metastasis at diagnosis between 2010 and 2016, along with data on a range of potential postoperative prognostic factors. We then investigated the potential postoperative prognostic roles of these factors using a Cox regression model and the Kaplan-Meier analysis. In all, the Surveillance, Epidemiology, and End Results database included 186 cases. Regarding overall survival, the 1-, 3-, and 5-year overall survival rates for the entire cohort were 36.2%, 15.4%, and 9.5%, respectively. Regarding cancer-specific survival, the 1-, 3-, and 5-year cancer-specific survival rates were 42.0%, 23.2%, and 16.6%, respectively. Within a cohort of melanoma patients with bone metastasis after surgery, our analysis showed that a smaller tumor size and the lack of metastases at other sites were predictors of survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024558","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:01:14Z","timestamp":1611914474000},"page":"e24558","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic factors for postoperative survival in melanoma patients with bone metastasis"],"prefix":"10.1097","volume":"100","author":[{"given":"Yucheng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Taizhou University Affiliated Municipal Hospital, Taizhou, Zhejiang"},{"name":"Hebei North University, Zhangjiakou, Hebei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihong","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The First People's Hospital of Wenling, Taizhou, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokang","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Taizhou University Affiliated Municipal Hospital, Taizhou, Zhejiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiacheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Taizhou University Affiliated Municipal Hospital, Taizhou, Zhejiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Taizhou University Affiliated Municipal Hospital, Taizhou, Zhejiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyang","family":"Cai","sequence":"additional","affiliation":[{"name":"Hebei North University, Zhangjiakou, Hebei"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Ruan","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Taizhou University Affiliated Municipal Hospital, Taizhou, Zhejiang"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev-pathol-052016-100208","article-title":"Signaling and immune regulation in melanoma development and responses to therapy","volume":"12","author":"Lin","year":"2017","journal-title":"Ann Rev Pathol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.addr.2017.09.016","article-title":"Targeted drug delivery to melanoma","volume":"127","author":"Liu","year":"2018","journal-title":"Adv Drug Delivery Rev"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bjd.15744","article-title":"Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?","volume":"177","author":"Smit","year":"2017","journal-title":"Br J Dermatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e2770","DOI":"10.1097\/MD.0000000000002770","article-title":"Incidence, surgical treatment, and prognosis of anorectal melanoma from 1973 to 2011: a population-based SEER analysis","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajo.2016.02.022","article-title":"Second primary neoplasms in patients with uveal melanoma: a SEER database analysis","volume":"165","author":"La\u00edns","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1002\/ijc.30407","article-title":"Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrence","volume":"139","author":"Rockberg","year":"2016","journal-title":"Int J Cancer"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1245\/s10434-015-4538-8","article-title":"Older age is associated with a higher incidence of melanoma death but a lower incidence of sentinel lymph node metastasis in the SEER databases (2003\u20132011)","volume":"22","author":"Cavanaugh-Hussey","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/codi.13412","article-title":"Extensive surgery and lymphadenectomy do not improve survival in primary melanoma of the anorectum: results from analysis of a large database (SEER)","volume":"19","author":"Ciarrocchi","year":"2017","journal-title":"Colorectal Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.jid.2016.05.121","article-title":"Miscoding of melanoma thickness in SEER: research and clinical implications","volume":"136","author":"Gimotty","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00066-017-1203-0","article-title":"Surgery vs. radiotherapy in patients with uveal melanoma: analysis of the SEER database using propensity score matching and weighting","volume":"193","author":"Jang","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"R11-20250504","first-page":"CD011123","article-title":"Systemic treatments for metastatic cutaneous melanoma","volume":"2","author":"Pasquali","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2007.12.7837","article-title":"Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials","volume":"26","author":"Korn","year":"2008","journal-title":"J Clin Oncol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/09546634.2017.1360987","article-title":"Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis","volume":"29","author":"Abdel-Rahman","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.adaj.2017.01.019","article-title":"Determining the epidemiologic, outcome, and prognostic factors of oral malignant melanoma by using the Surveillance, Epidemiology, and End Results database","volume":"148","author":"Lee","year":"2017","journal-title":"J Am Dent Assoc"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2340\/00015555-2944","article-title":"Effect of age on melanoma risk, prognosis and treatment response","volume":"98","author":"Ribero","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1016\/j.wneu.2019.07.095","article-title":"Primary malignant melanoma of the brain: a population-based study","volume":"130","author":"Puyana","year":"2019","journal-title":"World Neurosurg"},{"key":"R18-20250504","first-page":"210","article-title":"Temporal trends of incidence and mortality in Asian-Americans with pancreatic adenocarcinoma: an epidemiological study","volume":"33","author":"Gad","year":"2020","journal-title":"Ann Gastroenterol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/cam4.1152","article-title":"Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011","volume":"6","author":"Enninga","year":"2017","journal-title":"Cancer Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1158\/1078-0432.CCR-18-3340","article-title":"Correction: baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab","volume":"24","author":"Joseph","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.21873\/anticanres.13012","article-title":"Primary tumor size predicts distant metastasis of mucosal malignant melanoma in head and neck","volume":"38","author":"Suzuki","year":"2018","journal-title":"Anticancer Res"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.ophtha.2018.03.047","article-title":"Long-term metastatic risk after biopsy of posterior uveal melanoma","volume":"125","author":"Bagger","year":"2018","journal-title":"Ophthalmology"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2018.02.022","article-title":"Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy","volume":"127","author":"Gabani","year":"2018","journal-title":"Radiother Oncol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ijrobp.2019.03.041","article-title":"Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma","volume":"104","author":"Sundahl","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ijrobp.2017.11.029","article-title":"Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma","volume":"100","author":"Sundahl","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00280-014-2501-1","article-title":"Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)","volume":"74","author":"Xia","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.2016.71.8023","article-title":"Overall survival in patients with advanced melanoma who received nivolumab versus investigator's choice chemotherapy in CheckMate 037: a randomized, controlled, open-label phase III trial","volume":"36","author":"Larkin","year":"2018","journal-title":"J Clin Oncol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1177\/1078155218805539","article-title":"Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study","volume":"25","author":"Urun","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.37358\/RC.19.6.7314","article-title":"The evaluation of oxidative stress levels in obesity","volume":"70","author":"Mirela Elena","year":"2019","journal-title":"Revista de Chimie (Rev Chim)"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4239\/wjd.v11.i5.193","article-title":"Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with anthropometric and laboratory parameters","volume":"11","author":"G\u0103man","year":"2020","journal-title":"World J Diabetes"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/pcmr.12584","article-title":"Obesity and melanoma: could fat be fueling malignancy?","volume":"30","author":"Clement","year":"2017","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:30:04Z","timestamp":1746340204000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024558","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"2020-02-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}